SciELO - Scientific Electronic Library Online

 
vol.33 número2Identificación de Aislados de Cryptococcus neoformans Usando Agar Staib sin CreatininaEvaluación de la baciloscopia, cultivo y reacción en cadena de la polimerasa para el diagnóstico de tuberculosis pulmonar índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Kasmera

versión impresa ISSN 0075-5222

Resumen

ANTON, Dina et al. Phenotypic Characterization and Antimicrobial Susceptibility in Clinical Strains of Stenotrophomonas maltophilia. Kasmera [online]. 2005, vol.33, n.2, pp.109-118. ISSN 0075-5222.

Stenotrophomonas maltophilia, previously known as Xanthomonas maltophilia and Pseudomonas maltophilia, is a Gram negative rod, and a non fermentator of glucose, recognized as a causal agent of diverse hospital infections, it also shows resistance to multiple antimicrobial agents. The objective of the present study was to identify and to characterize phenol-type, clinical isolates of S. maltophilia, as well as to establish an in vitro activity pattern of different antimicrobials. The bacterial strains were isolatde in the Bacteriology Laboratory at the General Hospital in Cumaná, and were identified through conventional biochemical tests, as well as using the commercial galleries of API ID32GN. The MIC of the anti-microbes was determined by dilution in Mueller Hutton agar following CLSI norms. Pheno-typically, 24 strains were identified of S. maltophilia. The identification was 100% coincident with both classification techniques. The uniform pattern was maintained for the isolates except for the oxidase test, where 17 (70.83%) were positive and 7 (29.17%) negative. The results of the identification test showed the presence of 5 phenotypes in which the typical pattern of the microorganism (phenotype I, 14 isolates) prevailed. The strains showed 100% resistance to imipenem, cefepime, amikacin and nalidixico, 95.83% to cefotaxime, ceftazidime and ampicillin- sulbactam, 91,67% to ceftriaxone and ciprofloxacin, and 75.00% to piperacillin-tazobactam, all of which showed more susceptibility to trimetoprim sulfametoxazole (91.67%), levofloxacin (75%) and rifampin (95.83%)

Palabras clave : S. maltophilia; anti-microbials; susceptibility; phenotipification; nosocomial infections.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons